Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful?


  • Andrew Thomas Medical student, Sree Gokulam Medical College and Research Foundation, Trivandrum, India
  • Mohan T. Shenoy MBBS, MD, DM, Consultant Endocrinologist, Department of Endocrinology, Sree Gokulam Medical College and Research Foundation, Trivandrum, India
  • K.T. Shenoy MBBS, MD, DM, Professor and Head of department, Department of Gastroenterology, Sree Gokulam Medical College and Research Foundation, Trivandrum, India
  • Nirmal George MBBS, MD, Assistant Professor, Department of Pharmacology, Sree Gokulam Medical College and Research Foundation, Trivandrum, India



Blood Glucose Self-Monitoring, Type 2 Diabetes Mellitus, Glycemic Control, Blood glucose, Diabetes Complications


Background: The effectiveness of self-monitoring of blood glucose (SMBG) in type 2 diabetes mellitus (T2DM) patients is debated in the literature. We aimed at elucidating the association and patterns of complications between SMBG use and plasma glucose values.

Methods: This cross-sectional study comprised 303 participants from outpatient departments with T2DM for over 12 months. We analyzed sociodemographic and clinical variables including: anthropometry, SMBG use, disease duration, treatment modality, complications, plasma glucose level, and glycated hemoglobin level (%).

Results: The mean duration of T2DM was 93 ± 76 months. Participants were grouped into SMBG users (n=115, 38%) and non-SMBG users (n=188, 62%). The mean fasting plasma glucose levels of SMBG and non-SMBG users were 140.7±42.7 (95% Confidence Interval [95%CI]: 132.72;148.67) mg/dl and 145.4±50 (95%CI: 138.12;152.67) mg/dl (p=0.03), respectively. The mean post-prandial plasma glucose levels of the SMBG and non-SMBG groups were 202 ± 63.42 (95%CI: 190.23;213.76) mg/dl and 209±84.54 (95%CI: 196.56;221.43) mg/dl (p=0.002), respectively. The mean difference in HbA1c among the groups were 8.14±1.69% (95%CI: 7.59;8.68) and 8.15±1.98% (95%CI: 7.27;9.02) (p=0.4), respectively. Hypoglycemia (n=50, 43.5%) was the most common complication. The prevalence of neuropathy (n=5, 4.3%, p=0.036) and cardiovascular disease (n=21, 18.3%, p=0.042) were significantly higher in the SMBG group.

Conclusion: Although plasma glucose values were significantly lower in the SMBG group, its clinical significance remains questionable. Furthermore, many participants in both groups had shortfalls in awareness, monitoring, and glycemic control. SMBG use needs to be evaluated in a cohort of patients with T2DM with adequate health awareness.


Metrics Loading ...


Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australas Med J. 2014 Jan 31;7(1):45–8.

Colagiuri S, Sandbaek A, Carstensen B, Christensen J, Glumer C, Lauritzen T, et al.Comparability of venous and capillary glucose measurements in blood. Diabet Med. 2003 Nov;20(11):953-6.

Nair M, Prabhakaran D, Narayan KM, Sinha R, Lakshmy R, Devasenapathy N, et al. HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians. Prim Care Diabetes. 2011 Jul;5(2):95-102.

Thomas T, Prabhata S, Valsangkar S. Diabetes screening and the distribution of blood glucose levels in rural areas of North India. J Family Community Med. 2015 Sep-Dec;22(3):140-4.

Mohan V, Mapari J, Karnad P, Mann J, Maheshwari V. Reduced diabetes mellitus-related comorbidities by regular self-monitoring of blood glucose: Economic and quality of life implications. Indian J Endocr Metab. 2018;22(4):461.

Malanda UL, Bot SD, Nijpels G. Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: It is time to face the evidence. Diabetes Care. 2013 Jan 1;36(1):176–8.

AADE7™ Self-Care Behaviors. American Association of Diabetes Educators (AADE) Position Statement. 2014. Available from: Last updated December 03, 2014; cited Jun 29, 2019.

Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019 Mar;7(3):221-230.

Young LA, Buse JB, Weaver MA, Vu MB, Mitchell CM, Blakeney T et al. Glucose Self-Monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial. JAMA Intern Med. 2017 Jan;177(7):920–29.

Wang J, Zgibor J, Matthews JT, Charron-Prochownik D, Sereika SM, Siminerio L. Self-Monitoring of Blood Glucose Is Associated With Problem-Solving Skills in Hyperglycemia and Hypoglycemia. Diabetes Educ. 2021 Mar 1;38(2):207–18.

Farmer A, Balman E, Gadsby R, Moffatt J, Cradock C, McEwen L, et al. Frequency of Self-Monitoring of Blood Glucose in Patients with Type 2 Diabetes: Association with Hypoglycaemic Events. Curr Med Res Opin. 2008 Nov 1;24(11): 3097–104.

Iwuala SO, Olamoyegun MA, Sabir AA, Fasanmade OA. The relationship between self-monitoring of blood glucose and glycaemic control among patients attending an urban diabetes clinic in Nigeria. Ann Afr Med. 2015 Oct-Dec;14(4):182-7.

Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, et al. Self-Monitoring of Blood Glucose Significantly Improves Metabolic Control in Patients with Type 2 Diabetes Mellitus: The Auto-Surveillance Intervention Active (ASIA) Study. Diabetes Metab. 2003 Dec;29(6):587–94.

American Diabetes Association. Standards of medical care in diabetes. 2019. Available from Last updated January, 2019; cited Jun 29, 2019.

Mast O, Tan A, Punjabi K. Usage of Self-Monitoring of Blood Glucose (Smbg) By Diabetes Therapy Type in India. Value Health. 2014 Nov;17(7):A362.

Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version., cited Apr 24, 2019.

Heslehurst N, Sattar N, Rajasingam D, Wilkinson J, Summerbell CD, Rankin J. Existing maternal obesity guidelines may increase inequalities between ethnic groups: a national epidemiological study of 502,474 births in England. BMC Pregnancy Childbirth. 2012 Dec 18;12:156.

Ranganathan P, Pramesh CS, Buyse M. Common pitfalls in statistical analysis: Clinical versus statistical significance. Perspect Clin Res. 2015 Jul-Sep;6(3):169-70.

Monnier L, Colette C. Target for glycemic control: concentrating on glucose. Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S199-204.

Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K, et al. Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group. Diabetes Technol Ther. 2014 Jul;16(7):460-75.

O'Kane MJ, Bunting B, Copeland M, Coates VE, ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ. 2008 May 24;336(7654):1174-7.

International Diabetes Federation. Fact Sheet: Diabetes and Cardiovascular Disease (CVD). Available from Last updated June 29, 2019; cited Jun 29, 2019.

Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, et al. ADAG Study Group. HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia. 2011 Jan;54(1):69-72.

Huang IC, Wang PW, Liu RT, Tung SC, Chen JF, Kuo MC, et al The influence of self-monitoring blood glucose frequency on the oscillation of hemoglobin A1c and chronic complications. Chang Gung Med J. 2012 Jan-Feb;35(1):46-53.

Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton AM. Self-monitoring of blood glucose in type 2 diabetes: recent studies. J Diabetes Sci Technol. 2013 Mar 1;7(2):478-88.

Austin MM. Self-Monitoring of Blood Glucose in Type 2 Diabetes: Preface. Diabetes Spectrum, 2013;26(2):80–1.

Dudley JD. The diabetes educator's role in teaching the diabetic patient. Diabetes Care. 1980 Jan-Feb;3(1):127-33.

Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012 Jan 18;1:CD005060.

Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, et al. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):384-8.



How to Cite

Thomas, A., Shenoy, M. T., Shenoy, K., & George, N. . (2021). Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful?. International Journal of Medical Students, 9(2), 140–144.

Most read articles by the same author(s)